Select a medication above to begin.
Vectibix
panitumumab
Black Box Warnings .
Dermatologic Toxicity
reported in 90% of pts; 15% incidence of severe rxns
Adult Dosing .
Dosage forms: INJ
Special Note
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments
colorectal CA, metastatic
- [RAS wild-type dz, first-line tx]
- Dose: 6 mg/kg/dose IV x1 on day 1 of 14-day cycle; Info: use w/ FOLFOX as part of multi-drug chemo regimen
- [RAS wild-type dz, previously treated dz]
- Dose: 6 mg/kg/dose IV x1 on day 1 of 14-day cycle; Info: use as monotherapy in pts who have progressed after fluoropyrimidine-, oxaliplatin- and irinotecan-based tx
- [KRAS G12C-mutated dz, previously treated dz]
- Dose: 6 mg/kg/dose IV x1 on day 1 of 14-day cycle; Info: for pts who have received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based tx; use w/ sotorasib
renal dosing
- [see below]
- CrCl >30: no adjustment; CrCl <30: not defined
- HD/PD: not defined
hepatic dosing
- [see below]
- bilirubin 1-3x ULN: no adjustment; bilirubin >3x ULN: not defined
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.